tiprankstipranks
Trending News
More News >
NLS Pharmaceutics (NLSP)
NASDAQ:NLSP
US Market

NLS Pharmaceutics (NLSP) Income Statement

Compare
242 Followers

NLS Pharmaceutics Income Statement

Last quarter (Q2 2024), NLS Pharmaceutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, NLS Pharmaceutics's net income was $-2.04M. See NLS Pharmaceutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -11.41K$ -11.41K$ -10.05K$ 0.00$ 0.00
Operating Expenses
$ 11.81M$ 15.47M$ 11.85M$ 2.30M$ 4.20M
Depreciation and Amortization
$ 11.41K$ 11.41K$ 10.05K$ 2.30M$ 4.20M
EBITDA
$ -11.80M$ -15.47M$ -11.85M$ 0.00$ -430.40K
Operating Income
$ -11.81M$ -15.48M$ -11.86M$ -2.30M$ -4.20M
Other Income/Expenses
$ -364.97K$ -1.01M$ -85.46K$ -562.07K$ -1.25M
Pretax Income
$ -12.17M$ -16.50M$ -11.95M$ -2.86M$ -5.45M
Net Income
$ -12.17M$ -16.50M$ -11.95M$ -2.86M$ -5.45M
Per Share Metrics
Basic EPS
$ -0.32$ -0.84$ -0.81$ -0.59$ -0.49
Diluted EPS
$ -0.32$ -0.84$ -0.81$ -0.59$ -0.49
Weighted Average Shares Outstanding
38.18M 19.68M 14.75M 4.82M 11.14M
Weighted Average Shares Outstanding (Diluted)
38.18M 19.68M 14.75M 4.82M 11.14M
Currency in USD

NLS Pharmaceutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis